The site has had a layout overhaul (the changes in code are more than skin deep, though). On the data side, the emphasis is mostly on review and adding clinical information. As a ballpark estimate, gender and age information should be available for about half the cases - but this may take some months. Even followup / survival data will become accessible for a proportion of cases. Of course, this data is dependent on the published results, and / or the willingness of the authors to dig deeply into their old lab records ...
On the minus side, the case number just dropped slightly, to now 16998. This was due to one doubled publication entry, and one pure SKY data set that was removed (still accessible through NCBI).
As general policy, metaphase banding (incl. MFISH/SKY data) is only presented if it had been directly added to Progenetix (e.g. the DSMZ cell lines, or as part of some specific data review project). Otherwise, only cases with composite analysis (e.g. CGH and banding) are kept for now.
